Abstract
In patients with chronic myelomonocytic leukemia (CMML), age >65 years is an adverse prognostic factor. Our objective in the current study was to examine risk factors for survival and treatment outcome in 261 'young' adults with CMML, as defined by age
Original language | English |
---|---|
Pages (from-to) | e270 |
Journal | Blood Cancer Journal |
Volume | 5 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 1 2015 |
ASJC Scopus subject areas
- Oncology
- Hematology
- Medicine(all)